Fungi are increasingly causing life-threatening infections. Little is known about the mechanisms underlying these infections. We will compare the genomes of high and low virulent fungal strains to gain insides into the basis of these differences by using C. gattii as model of a globally highly pathogenic fungus. The findings will be generalized by comparing the obtained results with the genomes of other important pathogenic fungi to develop a scientific basis for better treatment strategies.
Novel Antibiotics That Harness Innate Immunity To Overcome Multi-drug Resistant S. Aureus
Funder
National Health and Medical Research Council
Funding Amount
$872,355.00
Summary
Controlling infection with antibiotics is essential in medicine. However, bacterial resistance to antibiotics is growing rapidly. Here, we propose new strategies to treat multi-drug resistant Staphylococcus aureus by combining existing clinical antibiotics with either a targetted immune response or by removing the ability of bacteria to hide from our immune system. These novel approaches will allow us to overcome infections caused by resistant bacteria, which are a serious and growing problem.
Characterisation Of Porphyromonas Gingivalis And Treponema Denticola Interactions In The Development Of A Pathogenic Biofilm
Funder
National Health and Medical Research Council
Funding Amount
$566,200.00
Summary
Gum disease (periodontitis) is an inflammatory disease caused by bacterial pathogens that is the major cause of tooth loss in adults. It is also associated with systemic diseases such as cardiovascular disease. In this study we will determine the mechanisms by which two bacterial species work together to produce the pathogenic dental plaque that causes disease.
Helicobacter Pylori Acquisition Of Host Cholesterol: Its Role In Inflammation
Funder
National Health and Medical Research Council
Funding Amount
$417,380.00
Summary
The bacterium Helicobacter pylori is present in the stomach of half the world’s population. It is estimated that 20% of these people will suffer from peptic ulcer disease, whereas as many as 1% will develop stomach cancer later in life. The common factor in all these diseases is the inflammation induced by the bacterium. This project will investigate a new mechanism by which H. pylori causes inflammation and how dietary cholesterol may be involved in this process.
Herpesviruses infect most Australians and cause recurrent ulcers, birth defects and cancer. Infection lasts lifelong, and spreads to close contacts without obvious clinical signs. Thus disease is hard to prevent. However we can learn much from related animal infections. We have shown that both mouse and human herpesviruses enter mice via cells in the nose. Thus human infections might follow the same route. We will define what body defences work here and whether vaccines can prevent infection.
Human ?-herpesviruses persist for life, cause cancers and emerge with particular virulence when the immune system is weak. Vaccination against them is therefore an important health priority. We have shown for a related ?-herpesvirus of mice that live vaccines protect. Antibody seems to play a major role. We will test whether safer, recombinant vaccines are also sufficient to elicit protective antibody. Thus we can establish a viable strategy for preventing virus-induced human cancers.